Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients
This study has been completed.
Study NCT00001937   Information provided by National Institutes of Health Clinical Center (CC)
First Received: January 18, 2000   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Aspergillosis
Candidiasis
Fungemia
Mycoses
Additional conditions recognized in this trial
Infection
More general conditions related to this trial
Inflammation
Pathologic Processes
Sepsis
Systemic Inflammatory Response Syndrome
Interventions listed in this trial
FK463
Fluconazole
Additional drug interventions recognized in this trial
Micafungin
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services